Navigation Links
Cell Culture Becomes an Integral Part of Cell Line Development and Engineering
Date:12/5/2012

LONDON, December 5, 2012 /PRNewswire/ --

- Market demands to reduce manufacturing costs require better Cell culture processes

According to further research conducted for the annual 2013 Cell Line Development & Engineering conference in Vienna next February, major developments in cell culture systems have given biotech's and pharmaceutical companies more flexibility to scale up cells to a high manufacturing quality. Cell engineering tools have enabled the production of high-performing cell lines and this has only been possible through improvements in cell culture media.

To best accommodate for these new developments, Informa Life Sciences' have expanded the programme to cover the latest in cell line development strategies and improvements in cell culture systems. Speaker Alison Porter, Head of Cell Line Development in the Mammalian Cell Culture group at Fujifilm Diosynth Biotechnologies (FFDB) clarifies how '‘With cell line construction on the critical path for first in human studies, it is vital to have optimised the early stages of cell line development. This can improve the future success of a biotherapeutic, both in terms of having the 'best' cell line and meeting increasingly tight timelines.'’

Further feedback from over 50 industry professionals and academics also highlight additional trends such as high throughput screening of cell lines, Quality by Design applications, cell line development strategies for novel products, analytical tools for product evaluation and bioinformatics applications.

Informa's annual 2013 Cell Line Development & Engineering conference has been designed to address topics essential to improve product development and quality. Susanna Benaim Conference Producer at Informa Life Sciences explains "The event uncovers the essentials in micro-scale system application, CHO genome sequencing, cell line engineering and targeted integration. The conference brings together leading experts from protein engineering, cell biology, cell line development and bioprocess, from both the pharmaceutical industry and academia. Any company specialising in this area is encouraged not to miss out."

Background

Cell Line Development & Engineering 2013 will take place on the 11th-15th February 2013 at the NH Atlanta in Vienna, Austria. With a sold-out attendance in 2012 and a packed exhibition room, the 2013 conference is already receiving support from some of the leading names and companies in the industry including;

  • Dr Sanjeev Gupta (Intas Pharma)
  • Dr Otfried Kistner (Baxter Innovations)
  • Dr Baisong Mei (Biogen Idec)
  • Prof Dr Nicole Borth (BOKU)
  • Dr Eric Becker (Boehringer Ingelheim)
  • Prof Florian Wurum (ExcellGene)
  • Dr Alison Potter (Fuji Film)
  • Dr Marcos Arauzo-Bravo (Max Planck)
  • Dr Martin Jordan (Merck Serono)
  • Prof Alan Dickson (Uni. of Manchester)
  • Prof David James (Uni. Of Sheffield)
  • Prof Nicolas Mermod (Uni. Of Lausanne)

Delegates and exhibitors can apply by registering online. For more information on how to register or to download a copy of the programme, please visit http://www.informa-ls.com/celldev

Other Related Events include;


Contacts:
Susanna Benaim
Conference Producer
Susanna.benaim@informa.com

James Miguel
Sales Director
James.miguel@informa.com



'/>"/>
SOURCE Informa Life Sciences
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Its Indiana State Fair Season: New BioCrossroads Report Emphasizes Opportunities in Food and Agriculture Innovation
2. PhoenixSongs Biologicals, Inc. Announces Enhanced Neural Lineage-specific Cell Culture Media Products Release
3. Prosperous Agriculture Reports Outstanding Sales Result for First Half of 2012
4. Elsevier Launches New Journal: Learning, Culture and Social Interaction
5. Nano-pesticides: Solution or threat for a cleaner and greener agriculture?
6. Carbon nanotubes can double growth of cell cultures important in industry
7. Health Diagnostic Laboratory Names Scott Blackwell Vice President of Corporate Culture
8. Farm weeds have crucial role in sustainable agriculture
9. Mesenchymal Stem Cells Have New Cell Culture Environment
10. India In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture
11. MO BIO Laboratories, Inc. Becomes Exclusive Sponsor Of Natures Human Microbiota Special
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... , Feb. 22, 2017 Aethlon Medical, Inc. ... of a study that validated the ability of the ... associated with increased mortality in immune-suppressed sepsis patients and ... The objective of the study was to ... (CMV), Epstein-Barr virus (EBV) and Herpes Simplex virus 1 ...
(Date:2/22/2017)... N.C., Feb. 22, 2017  United Therapeutics Corporation (NASDAQ: ... results for the fourth quarter and year ended ... results reflect continued growth as net revenues reached ... Martine Rothblatt, Ph.D., United Therapeutics, Chairman and Chief ... to develop and advance our growing product pipeline, ...
(Date:2/21/2017)... ... February 21, 2017 , ... Vortex ... , a fully automated benchtop system for collecting intact circulating tumor cells (CTCs) ... at the Molecular Medicine Tri Conference (Tri-Con) Annual Meeting 2017 (February 19–24 San ...
(Date:2/21/2017)... ... February 21, 2017 , ... ... Treximo will pair its $200M operational capacity with its strategic internal leadership ... in areas affecting quality and operational management. With office locations in ...
Breaking Biology Technology:
(Date:2/8/2017)... The biometrics market has reached a ... organizations, desires to better authenticate or identify users ... challenge questions), biometrics is quickly working its way ... is driven by use cases, though there traditionally ... uses cases, with consumer-facing use cases encompassing authentication, ...
(Date:2/7/2017)... , Feb. 7, 2017   MedNet Solutions , ... entire spectrum of clinical research, is pleased to announce ... , its innovative, highly flexible and award winning eClinical ... customers. iMedNet is a proven Software-as-a-Service (SaaS) ... Data Capture (EDC), but also delivers an entire suite ...
(Date:2/7/2017)... New York , February 7, 2017 ... as ID Global Solutions Corporation [OTC: IDGS], ("Ipsidy" or ... management and electronic transaction processing services, is pleased to ... of the Company. Effective January 31, 2017, ... the Board of Directors, CEO and President.  An experienced ...
Breaking Biology News(10 mins):